Importance of pharmacogenetics for therapeutic use of clopidogrel
Cerebrovascular and cardiovascular diseases are the worldwide leading causes of mortality. Therefore, therapy of these diseases is of great importance. Antiplatelet therapy with clopidogrel alone and in combination with aspirin has a prominent place. The major problem in clopidogrel therapy is patie...
Main Authors: | Rančić Nemanja, Kovačević Aleksandra, Simić-Dragojević Viktorija |
---|---|
Format: | Article |
Language: | English |
Published: |
Medicinsko društvo za racionalnu terapiju Republike Srbije
2013-01-01
|
Series: | Racionalna Terapija |
Subjects: | |
Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/1821-0538/2013/1821-05381302075R.pdf |
Similar Items
-
THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY
by: V. V. Yakusevich, et al.
Published: (2016-01-01) -
Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática Clinical relevance of clopidogrel and omeprazole interaction: systematic review
by: Héctor Holguín, et al.
Published: (2012-01-01) -
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
by: Bhawani Yasassri Alvitigala, et al.
Published: (2020-12-01) -
Influence of statin treatment on pharmacokinetics and pharmacodynamics of clopidogrel and its metabolites in patients after coronary angiography/angioplasty
by: Marta Karaźniewicz-Łada, et al.
Published: (2019-08-01) -
Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
by: Dongwhane Lee, et al.
Published: (2018-09-01)